IPSEN PHARMA

In News

Ipsen announces the availability of its 2025 Universal Registration Document - au.finance.yahoo.com

au.finance.yahoo.com - Apr 01, 2026

Ipsen to withdraw cancer drug acquired in buyout due to safety concerns - biopharmadive.com

biopharmadive.com - Mar 09, 2026

Ipsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial - fiercepharma.com

fiercepharma.com - Mar 09, 2026

Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail - Fierce Biotech

Fierce Biotech - Dec 19, 2025

Ipsen appoints Michelle Werner as Executive Vice President, President of North America - pmlive.com

pmlive.com - Mar 30, 2026

Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR - globenewswire.com

globenewswire.com - Mar 18, 2026

Ipsen announces new data on Dysport in neurological disease - PharmaTimes

PharmaTimes - Jan 15, 2026

Ipsen announced overall Pharma Industry Company of the Year in 2021 Pharma Industry Awards - UK Ireland - Ipsen

Ipsen - Nov 28, 2025

Ipsen selects Pierrick Lefranc as new EVP Technical Operations - europeanpharmaceuticalreview.com

europeanpharmaceuticalreview.com - Jan 27, 2026

Ipsen outlays $1bn for China-based Simcere’s preclinical ADC - pharmaceutical-technology.com

pharmaceutical-technology.com - Dec 23, 2025

Ipsen shares soar on stellar results - thepharmaletter.com

thepharmaletter.com - Feb 12, 2026

Assessing Ipsen (ENXTPA:IPN) Valuation After New Preclinical Oncology Data At AACR - simplywall.st

simplywall.st - Mar 29, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment